Pseudotyping Vesicular Stomatitis Virus with Lymphocytic Choriomeningitis Virus Glycoproteins Enhances Infectivity for Glioma Cells and Minimizes Neurotropism

Oncolytic viruses as experimental treatments for malignant gliomas: Using a scourge to treat a devil

(2010) Franz J. Zemp et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Pseudotype-dependent lentiviral transduction of astrocytes or neurons in the rat substantia nigra

(2010) Jason R. Cannon et al.   EXPERIMENTAL NEUROLOGY

Fusion-active glycoprotein G mediates the cytotoxicity of vesicular stomatitis virus M mutants lacking host shut-off activity

(2010) M. Hoffmann et al.   JOURNAL OF GENERAL VIROLOGY

Distinct Functions of Glial and Neuronal Dystroglycan in the Developing and Adult Mouse Brain

(2010) J. S. Satz et al.   JOURNAL OF NEUROSCIENCE

Viruses, gene therapy and stem cells for the treatment of human glioma

(2009) A P Kyritsis et al.   CANCER GENE THERAPY

Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity

(2009) E J Ilett et al.   GENE THERAPY

Some Attenuated Variants of Vesicular Stomatitis Virus Show Enhanced Oncolytic Activity against Human Glioblastoma Cells relative to Normal Brain Cells

(2009) G. Wollmann et al.   JOURNAL OF VIROLOGY

Attenuation of Vesicular Stomatitis Virus Encephalitis through MicroRNA Targeting

(2009) E. J. Kelly et al.   JOURNAL OF VIROLOGY

Phase Ib Trial of Oncolytic Herpes Virus G207 Shows Safety of Multiple Injections and Documents Viral Replication

(2008) Manish K Aghi et al.   MOLECULAR THERAPY